BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35478139)

  • 1. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
    Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
    In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
    Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
    Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
    Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
    Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.
    Zou DD; Sun YZ; Li XJ; Wu WJ; Xu D; He YT; Qi J; Tu Y; Tang Y; Tu YH; Wang XL; Li X; Lu FY; Huang L; Long H; He L; Li X
    Elife; 2023 Dec; 12():. PubMed ID: 38099574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
    Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM
    Arch Dermatol Res; 2022 Apr; 314(3):257-266. PubMed ID: 33813600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines.
    Christensen RE; Elston DM; Worley B; Dirr MA; Anvery N; Kang BY; Bahrami S; Brodell RT; Cerroni L; Elston C; Ferringer T; Hurley MY; Garton K; Lee JSS; Liu Y; Maize JC; McNiff JM; Rapini RP; Sangueza OP; Shea CR; Zhou C; Alam M
    J Am Acad Dermatol; 2023 Jun; 88(6):1317-1325. PubMed ID: 36841336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high-risk actinic keratosis.
    Lee JS; Park HS; Yoon HS; Cho S
    Clin Exp Dermatol; 2019 Jul; 44(5):483-490. PubMed ID: 30315595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
    Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
    Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition contributes to invasion in squamous cell carcinomas originated from actinic keratosis through the differentiated pathway, whereas proliferation plays a more significant role in the classical pathway.
    Saenz-Sardà X; Carrato C; Pérez-Roca L; Puig L; Ferrándiz C; Ariza A; Fernández-Figueras MT
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):581-586. PubMed ID: 28796927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
    Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
    Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
    Karagece Yalçin U; Seçkın S
    Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients.
    Shibayama Y; Imafuku S
    J Dermatol; 2014 Dec; 41(12):1102-5. PubMed ID: 25385075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.
    Miola AC; Castilho MA; Schmitt JV; Marques MEA; Miot HA
    An Bras Dermatol; 2019; 94(6):698-703. PubMed ID: 31789247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.
    Ratushny V; Gober MD; Hick R; Ridky TW; Seykora JT
    J Clin Invest; 2012 Feb; 122(2):464-72. PubMed ID: 22293185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
    Feldman SR; Fleischer AB
    Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis].
    Dornelas MT; Rodrigues MF; Machado DC; Gollner AM; Ferreira AP
    An Bras Dermatol; 2009; 84(5):469-75. PubMed ID: 20098848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoexpression of Ki67, P16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma.
    Vîlcea AM; Stoica LE; Andreiana BC; Mirea CS; Ţenea Cojan TŞ; Vîlcea IC; Mărgăritescu C
    Rom J Morphol Embryol; 2024; 65(1):19-25. PubMed ID: 38527980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.
    Zamirska A; Matusiak Ł; Dziegiel P; Szybejko-Machaj G; Szepietowski JC
    Pathol Oncol Res; 2012 Oct; 18(4):849-55. PubMed ID: 22407324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
    Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
    J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.